An analysis of the tumor microenvironment showing a low CD3+ T cell infiltrate and PDL1 expression raises questions about the prognostic factors for response to immunotherapy in wild-type GIST (11). The gene discussed is CD274; the disease is gastrointestinal stromal tumor.